Novel insights into chronic rhinosinusitis with nasal polyps

Novel insights into chronic rhinosinusitis with nasal polyps

Dupilumab improves outcomes in patients with chronic rhinosinusitis with nasal polyps and a type 2 inflammatory signature irrespective of definition

Prospective analysis of SNOT22 score in a cohort of patients affected by CRSwNP treated with biotechnological drugs